{"database": "open_comments", "table": "documents", "rows": [["FDA-2018-D-4533-2363", "FDA", "FDA-2018-D-4533", "Compounding Animal Drugs From Bulk Drug Substances: Compounding Under CGMP in Federally-Registered Facilities; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request", "Notice", "Notice of Availability", "2026-08-28", 2026, 8, "2026-08-28", "2026-11-27", "2026-11-28 04:59:59", 0, "2026-08-28 16:31:49", "2026-17580", 1, 0, "09000064b94a6448"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "comment_end_datetime", "perpetual_docket", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2018-D-4533-2363"], "units": {}, "query_ms": 0.21045608446002007, "source": "U.S. government sources, plus a few identifier registries; each is listed on the methodology page", "source_url": "https://datadawn.org/methodology#data", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}